DAY 1: Growing Pains - Preparing for Growth

Growing Pains: Stories from the Trenches 
Hear from companies that have been there – what were their issues and how did they overcome them? Benefit from their experience, avoid their pitfalls, and accelerate your company to the next level.   
    Greg Baldwin, Baxter
    Tom Cycyota, Allosource    
    Scott Deeter, Ventria
    Woody Emlen, Taligen Therapeutics 
                 
Best Practices for R&D, Product Development and Clinical Trials
Hear how companies are developing products on tight budgets, determining when a product is ready to launch, and identifying the right markets.     
    Bruce Eaton, SomaLogic
    Gwyn Wold, Clovis Oncology
    Moderator: Dr. Michael Bristow, ARCA Biopharma

Best Practices for Manufacturing and Outsourcing
Outsourcing has been common in the electronics industry for two decades.  However, medical device and biotech companies are now outsourcing to reduce expense and business complexity. Learn about appropriate uses of outsourcing to reduce costs and time to market and potential issues and pitfalls.
    Joe Guiles, Cedarburg Hauser 
    Rose Lopez, Merck    
    Moderator: Pat Linden, Faegre Baker Daniels

Keynote Lunch Speaker: Pat Mahaffy, Clovis Oncology

Financing Part 1 (Company-Perspective):
Tips to Attract Funding and Keys to Successful Founder-Investor Relationships: You have heard what funding sources are available. Now hear practical tips on surviving the fundraising process, closing the deal and maintaining successful relationships with your investors post-closing.     
    Larry Blankenship, ValveXChange
    Dan Hudspeth, Industry Consultant, Cohesive Strategy    
    Karen Padgett, Novus Biologicals
    Moderator: Derek Cole, ARCA Biopharma and Board Member, National Investor Relations Institute

Update from Washington:  FDA, User Fees, and Health Care Reform
    Vince Ventimiglia, Faegre Baker Daniels Consulting presentation

Financing Part II:
Due Diligence – How do you Prepare for Investors and Strategic Partners?
   Chris Kujawa, Ernst & Young

Changing the Regulatory Rules:
Getting Your Product on the Market Through the Revised 510(k) and PMA Processes
   Ralph Hall, Advisor FaegreBD Consulting presentation 

DAY 2: Advanced IP Protection and Licensing Matters

What is your intellectual property and your company worth?
Find out how are valuations done and how to decide if you should get one.      
    Dan Ross, PriceSpective presentation

Best Practices for Protecting an IP Portfolio and Managing Outside Counsel
Hear successful strategies and practical tips for evaluating your patents, trademark and trade secrets, leveraging your intellectual portfolio, and keeping costs down. 
    Jim Chomas, Surefire Medical
    Jodie Currie, MedEfficiency, Inc.
    Denise Kettelberger, Faegre Baker Daniels
    John Emanuele, Faegre Baker Daniels
    Moderator: Roberta Hanson, Faegre Baker Daniels

Keynote Lunch Speaker: Mats Wahlström, previous Co-CEO of Fresenius Medical Care North America, and current CEO and Chairman of Leonard Capital, LLC
What Can You Learn from Your Failures and Successes? presentation

Developing an IP Licensing Strategy
You have an iron-clad IP portfolio - what will you do with it?
Or, your IP portfolio has a few holes – how can you fill them?
Hear how to maximize the value of your IP portfolio and the various development alternatives, market terms, strategies for dealing with licensing partners. 
    Rick Jory, Sandhill Scientific, Inc
    John Merkling, TerumoBCT
    Jim Kasic, Sophono
    Terry Opgenorth, CSU Ventures, C2D2
    Moderator: Ben Fernandez, Faegre Baker Daniels  

Avoiding Legal Landmines for FDA Regulated Products
    Amy Judge-Prein, Faegre Baker Daniels , presentation